Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 98263
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.98263
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.98263
Total (n = 57) | Residual disease (n = 40) | Complete response (n = 17) | P value | |
CR | 12 (21.1) | 1 (2.5) | 11 (64.7) | < 0.01 |
NCR | 17 (29.8) | 12 (30.0) | 5 (29.4) | 0.96 |
PR | 23 (40.4) | 22 (55.0) | 1 (5.9) | < 0.01 |
SD | 5 (8.8) | 5 (12.5) | 0 (0) | 0.31 |
- Citation: Li YG, Han CC, Zhuang M, Zhao W, Hu G, Qiu WL, Wang XS, Tang JQ. Evaluating the predictive value of endoscopic findings for residual colorectal cancer following neoadjuvant combination immunotherapy. World J Gastrointest Surg 2025; 17(1): 98263
- URL: https://www.wjgnet.com/1948-9366/full/v17/i1/98263.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.98263